• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nuvation Bio Inc. Class A Common Stock (NY:NUVB)

4.490 +0.040 (+0.90%)
Official Closing Price Updated: 7:00 PM EDT, May 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,643,623
Open 4.450
Bid (Size) 4.430 (300)
Ask (Size) 4.510 (100)
Prev. Close 4.450
Today's Range 4.380 - 4.530
52wk Range 1.570 - 9.750
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Insider Sells 200K Shares of Biotech Company Nuvation Bio (NUVB) ↗
April 13, 2026
This oncology-focused biotech, advancing multiple clinical-stage therapeutics, just reported a notable insider sale in recent filings. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
March 24, 2026
From Pomerantz LLP
Via GlobeNewswire

Performance

YTD
-47.7%
-47.7%
1 Month
+1.8%
+1.8%
3 Month
-20.2%
-20.2%
6 Month
-13.2%
-13.2%
1 Year
+82.5%
+82.5%

More News

Read More
News headline image
NUVB Investors Have Opportunity to Join Nuvation Bio Inc. Fraud Investigation with the Schall Law Firm
March 21, 2026
From The Schall Law Firm
Via Business Wire
NUVATION BIO INC (NYSE:NUVB) Stock Plunges 9% After Q4 Earnings Reveal Revenue Beat but Wider Loss ↗
March 02, 2026
Via Chartmill
Nuvation Bio Stock Logs Its Best Session Ever: Wall Street Turns Bullish On Lung Cancer Drug’s Blockbuster Debut ↗
November 20, 2025
Via Stocktwits
News headline image
Earnings Scheduled For November 3, 2025 ↗
November 03, 2025
Via Benzinga
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
March 17, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
March 10, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
SSR Mining Stock Up 180% as New $5 Million Stake Signals Gold Conviction ↗
March 03, 2026
Via The Motley Fool
Topics ETFs Regulatory Compliance
News headline image
Nuvation Bio Stock Up 130% This Past Year as One Fund Discloses $3 Million Buy ↗
March 03, 2026
Via The Motley Fool
Topics Regulatory Compliance
Which stocks are gapping on Tuesday? ↗
March 03, 2026
Via Chartmill
News headline image
Nuvation Bio (NUVB) Q4 2025 Earnings Transcript ↗
March 03, 2026
Via The Motley Fool
News headline image
Nuvation Bio Announces Pivotal Global Phase 3 SIGMA Trial (G203) for Safusidenib in IDH1-Mutant Glioma
February 09, 2026
From Nuvation Bio
Via Business Wire
News headline image
Nuvation Bio Reports Preliminary Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook Ahead of 44th Annual J.P. Morgan Healthcare Conference
January 12, 2026
From Nuvation Bio
Via Business Wire
News headline image
Nuvation Bio and Eisai Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside U.S., China and Japan
January 12, 2026
From Nuvation Bio and Eisai
Via Business Wire
News headline image
Nuvation Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 06, 2026
From Nuvation Bio
Via Business Wire
News headline image
Nuvation Bio Announces Publication of Positive Phase 2 Study Results for Safusidenib for the Treatment of Grade 2 IDH1-Mutant Glioma in Neuro-Oncology
December 03, 2025
From Nuvation Bio
Via Business Wire
News headline image
Nuvation Bio to Participate in Upcoming Investor Conferences
November 26, 2025
From Nuvation Bio
Via Business Wire
News headline image
Nuvation Bio (NUVB) Soars on IBTROZI's Blockbuster Launch and Stellar Q3 2025 Performance
November 19, 2025
Via MarketMinute
News headline image
Which stocks are moving on Wednesday? ↗
November 19, 2025
Via Chartmill
News headline image
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
November 19, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
November 19, 2025
Via Benzinga
News headline image
Nuvation Bio (NUVB) Q3 2025 Earnings Transcript ↗
November 04, 2025
Via The Motley Fool
Topics Earnings
News headline image
Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
November 03, 2025
From Nuvation Bio Inc.
Via Business Wire
News headline image
Nuvation Bio Chief Scientist Sells 100,000 Shares Under Trading Plan — Here's What to Know About the Stock ↗
November 03, 2025
Via The Motley Fool
Topics Regulatory Compliance

Frequently Asked Questions

Is Nuvation Bio Inc. Class A Common Stock publicly traded?
Yes, Nuvation Bio Inc. Class A Common Stock is publicly traded.
What exchange does Nuvation Bio Inc. Class A Common Stock trade on?
Nuvation Bio Inc. Class A Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Nuvation Bio Inc. Class A Common Stock?
The ticker symbol for Nuvation Bio Inc. Class A Common Stock is NUVB on the New York Stock Exchange
What is the current price of Nuvation Bio Inc. Class A Common Stock?
The current price of Nuvation Bio Inc. Class A Common Stock is 4.490
When was Nuvation Bio Inc. Class A Common Stock last traded?
The last trade of Nuvation Bio Inc. Class A Common Stock was at 05/01/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap